Delirium tremens

Reading File

Finding Sources

Searching PubMed

"delirium tremens" AND "alcohol withdrawal"

Reading File

Finding Sources

Reading File

I now have rich, comprehensive information from multiple authoritative textbooks. Let me compile the full response.

Delirium Tremens (DTs)

Definition

Delirium tremens is the most severe and life-threatening manifestation of alcohol withdrawal. It is characterized by an acute, fluctuating disturbance in consciousness with profound confusion, vivid hallucinations (especially tactile and visual), psychomotor agitation, delusions, and marked autonomic hyperactivity. It represents the full end of the alcohol withdrawal spectrum and carries a significant mortality risk if untreated.

Tintinalli's Emergency Medicine, p. 1265
Adams and Victor's Principles of Neurology, 12th Ed.

Pathophysiology

Alcohol (ethanol) has a dual mechanism at baseline:

Enhances GABA-A receptor function - producing inhibitory/anxiolytic effects
Attenuates NMDA receptor (NMDAR) function - reducing excitatory neurotransmission

With chronic heavy alcohol use, the brain compensates through:

Downregulation of GABA-A receptors
Upregulation of NMDARs (supersensitivity)

When alcohol is abruptly discontinued, this compensation is suddenly unmasked - the inhibitory GABA system is underactive while the excitatory glutamate/NMDA system is overactive, producing a hyperexcitable state. This neurochemical imbalance is the substrate for seizures, delirium, and autonomic storm.

"Persistent abuse and dependency on ethanol result in a downregulation of GABA A receptors and an upregulation of NMDARs such that acute discontinuation of ethanol results in a hyperexcitable state characterized by delirium tremens." - Kaplan & Sadock's Comprehensive Textbook of Psychiatry

Additionally, NMDAR supersensitivity in the context of thiamine deficiency can contribute to the excitotoxic neurodegeneration seen in Wernicke-Korsakoff syndrome, which may co-exist with DTs.

Epidemiology and Risk Factors

About 5% of hospitalized alcohol-dependent patients develop DTs
Historical mortality was ~15%; with modern treatment it is closer to 2-5%, though some series report up to 8% in severely ill populations
DTs typically begin in patients in their 30s-40s after 5-15 years of heavy (often binge-pattern) drinking
Physical illness (hepatitis, pancreatitis) is a strong predisposing factor; patients in good physical health rarely develop DTs

Risk factors include:

Prior DT episodes or withdrawal seizures
Severe alcohol dependence / prolonged high-volume intake
Prior detoxification history
Older age
Polydrug use
Comorbid medical illness
Elevated blood pressure on admission
Genetic polymorphisms

Clinical Presentation

Timing

Symptoms of uncomplicated withdrawal begin 6-24 hours after the last drink
DTs typically emerge 48-96 hours (2-4 days) after cessation - patients admitted for unrelated reasons often develop DTs on hospital day 3
A patient may pass through tremulousness, hallucinosis, and seizures before DTs fully develop, or DTs may appear as the first sign

Core Features (Table 4-6, Kaplan & Sadock's Synopsis of Psychiatry)

Category	Symptoms
Delirium	Confusion, disorientation, disorganized thinking
Hallucinations	Tactile (most characteristic - formication/"bugs crawling"), visual, less commonly auditory
Delusions	Often paranoid/persecutory
Autonomic hyperactivity	Tachycardia, diaphoresis, fever, hypertension
Other	Anxiety, insomnia, severe tremor, fluctuating psychomotor activity (lethargy to severe agitation)

The classic description from Adams and Victor's: "profound confusion, delusions, vivid hallucinations, tremor, agitation, and sleeplessness, as well as dilated pupils, fever, tachycardia, and profuse perspiration."

Course

In >80% of cases, when DTs occur as a single episode, duration is 72 hours or less
The episode often ends abruptly - the patient falls into deep sleep and awakens lucid and exhausted, with little memory of the delirious period
Less commonly the delirium subsides gradually with relapses; the entire process can last up to 4-5 weeks
Pathologic examination is unrevealing; cerebral edema is absent unless shock/hypoxia occurred

Differential Diagnosis

Conditions to exclude before diagnosing DTs:

Wernicke's encephalopathy (may co-exist - thiamine must always be given)
Benzodiazepine or barbiturate withdrawal (nearly identical presentation)
Hepatic encephalopathy
CNS infection (meningitis, encephalitis)
Hypoglycemia
Sepsis / systemic infection
Anticholinergic toxidrome
Sympathomimetic intoxication

A key clinical point: benzodiazepine withdrawal can appear identical to DTs, with onset dependent on the half-life of the specific agent used.

Management

Goals

Suppress CNS hyperexcitability and autonomic storm
Prevent seizures and progression to fatal DTs
Correct metabolic derangements
Prevent and treat complications
Motivate long-term abstinence

First-Line: Benzodiazepines

No single benzodiazepine is superior to another. IV route works fastest:

Diazepam: onset 1-5 min IV
Midazolam: onset 2-5 min IV
Lorazepam: onset 5-20 min IV (IM absorption is adequate, unlike diazepam where IM absorption is erratic)

DT-specific dosing (Tintinalli's):

Lorazepam 2-4 mg IV; double the dose and repeat every 15-20 min until light somnolence
Diazepam 10-20 mg IV over 2 min; double the dose and repeat every 5-10 min until light somnolence

The principle is symptom-triggered dosing to clinical endpoint, not a fixed schedule.

Refractory DTs

When benzodiazepines fail to control DTs:

Agent	Dose / Notes
Phenobarbital	65 mg IV every 15-30 min to max 260 mg; respiratory depression more common than with benzodiazepines - typically requires intubation
Propofol	5 mcg/kg/min (0.3 mg/kg/hr) titrated to effect; requires intubation (primarily case reports)
High-dose phenobarbital	Up to 1,500-2,000 mg on day 1 as alternative in severe cases
Propofol (higher dose)	Up to 4 mg/kg/hr for severe intractable withdrawal delirium in intubated patients
ECT	Considered in extreme refractory cases, as it is effective for delirium of any cause

Essential Supportive Measures

Thiamine (100-500 mg IV) immediately - before any dextrose - to prevent/treat Wernicke's encephalopathy
Fluid and electrolyte replacement (hyponatremia, hypomagnesemia, hypophosphatemia are common)
Glucose supplementation (after thiamine)
Monitoring and treatment of hyperthermia
Cardiac monitoring (autonomic instability can cause arrhythmias)
Seizure management (benzodiazepines cover both withdrawal seizures and DTs)
Folic acid and multivitamins

Prognosis and Complications

With treatment, the vast majority recover fully
Mortality in treated patients: ~2-5% (historically 15%)
Deaths often occur due to:
- Hyperthermia
- Cardiovascular collapse from sympathetic activation
- Associated liver failure or infection
- Sudden cardiac death (mechanism unclear)
Reports of "negligible mortality" in DTs usually reflect misclassification - inclusion of milder withdrawal syndromes which are far more common and practically never fatal

Key Distinction: DTs vs. Alcohol-Induced Psychotic Disorder

Feature	Delirium Tremens	Alcohol-Induced Psychotic Disorder
Timing	2-4 days after cessation	Within 2 weeks of consumption; persists >48h after withdrawal
Hallucinations	Tactile > visual	Auditory predominate
Sensorium	Clouded (delirium)	Relatively clear
Autonomic changes	Prominent	Minimal
Treatment	Benzodiazepines	Antipsychotics

Recent Evidence

A 2025 systematic review (Faustmann et al., Fortschr Neurol Psychiatr, PMID 36958342) examined antipsychotic treatment in alcohol withdrawal with a focus on DTs. The review supports benzodiazepines as the primary treatment but identifies a role for antipsychotics as adjuncts in patients with refractory agitation or prominent psychotic features - consistent with current emergency medicine practice.

Sources:

Tintinalli's Emergency Medicine: A Comprehensive Study Guide, pp. 1265-1266
Adams and Victor's Principles of Neurology, 12th Ed.
Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Kaplan and Sadock's Synopsis of Psychiatry (Table 4-6)
Frameworks for Internal Medicine
Plum and Posner's Diagnosis and Treatment of Stupor and Coma

This is a shared conversation. Sign in to Orris to start your own chat.